SLC1A3 and cancer: Further research suggests that CAFs can transfer aspartate to cancer cells via the SLC1A3 transporter (also known as excitatory amino acid transporter 1 [EAAT1]), to facilitate nucleotide synthesis in the tumor cells [53], whereas glutamine-derived glutamate from cancer cells is taken up by CAFs through the same transporter.